Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
Lineage reports Q2 2026 results, advances COR1 corneal program and OpRegen dataAug 6Quarterly updateLineage Cell Therapeutics, Inc.Opregen